| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.06 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.069 | 0.06 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | 0.068 | 0.06 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.06 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.06 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.069 | 0.06 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.07 | 0.06 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.088 | 0.06 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.058 | 0.06 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.063 | 0.06 |